home / stock / tnya / tnya news

TNYA News and Press, Tenaya Therapeutics Inc. From 05/10/23

Stock Information
Company Name: Tenaya Therapeutics Inc.
Stock Symbol: TNYA
Market: NASDAQ
Website: tenayatherapeutics.com
Menu
TNYA TNYA Quote TNYA Short TNYA News TNYA Articles TNYA Message Board
Get TNYA Alerts

News, Short Squeeze, Breakout and More Instantly...
TNYA - Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update

TN-201 Received Fast Track Designation from the FDA Dosing Complete in Phase 1 Clinical Trial of TN-301; Data Expected in Second Half 2023 Renowned Researchers Drs. Christine Seidman and Alex Marson Join Scientific Advisory Board Announces Formation of Technical Advisory B...
TNYA - Immuron, ANI Pharmaceuticals top healthcare gainers; Catalent, Aptorum among losers

2023-05-08 10:03:22 ET Gainers: Immuron ( IMRN ) +49% . ANI Pharmaceuticals ( ANIP ) +17% . MiNK Therapeutics ( INKT ) +13% . Evaxion Biotech ( EVAX ) +8% . Predictive Oncology ( POAI ) +8% . Losers: Catalent ( CTLT ) ...

TNYA - Tenaya Highlights Growing Capabilities in AAV Manufacturing, Capsid Engineering and Expansion into Gene Editing with Six Abstracts Accepted for Presentation at the ASGCT 26th Annual Meeting

SOUTH SAN FRANCISCO, Calif., May 03, 2023 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, announced that several...

TNYA - Tenaya's gene therapy TN-201 for heart disorder gets FDA fast track tag

2023-05-02 09:14:34 ET The U.S. Food and Drug Administration (FDA) granted fast track designation to Tenaya Therapeutics' ( NASDAQ: TNYA ) gene therapy TN-201 being developed to treat Myosin Binding Protein C3 (MYBPC3)-associated hypertrophic cardiomyopathy (HCM). HCM ...
TNYA - Tenaya Therapeutics Receives FDA Fast Track Designation for TN-201

TN-201 Being Developed for the Potential Treatment of MYBPC3-associated HCM Dosing in Phase 1 Clinical Trial Expected to Commence in Q3 2023 SOUTH SAN FRANCISCO, Calif., May 02, 2023 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology compa...

TNYA - The 7 Best Biotech Stocks for Personalized Medicine Investors

2023-04-25 06:35:25 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Personalized medicine stocks are hot right now. This form of medicine based on the particular genes, proteins, and other substances in a person’s body. It promises to revolutio...

TNYA - Tenaya Therapeutics to Participate at Chardan's 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

SOUTH SAN FRANCISCO, Calif., April 21, 2023 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that...
TNYA - FENG, ALXO and GFAI among mid-day gainers

2023-04-21 13:53:45 ET Gainers: Presto Automation ( PRST ) +49% . CBL International Limited ( BANL ) +34% . EyePoint Pharmaceuticals EYPT +31% . Asset Entities ( ASST ) +25% . ContextLogic ( WISH ) +24% . Mullen Automotive ( MU...

TNYA - EyePoint, Tenaya top healthcare gainers; Aditxt, Ocuphire among losers

2023-04-21 10:03:36 ET Gainers: EyePoint Pharmaceuticals ( EYPT ) +19% . Tenaya Therapeutics ( TNYA ) +21% . Community Health Systems ( CYH ) +11% . NovaBay Pharmaceuticals ( NBY ) +11% . Aziyo Biologics ( AZYO ) +8% . Loser...

TNYA - Why This Nasdaq Stock Caught Fire This Week

2023-04-20 14:46:29 ET Shares of the clinical-stage gene therapy company Tenaya Therapeutics (NASDAQ: TNYA) rose by a staggering 49% over the first three and a half days of trading this week, according to data provided by S&P Global Market Intelligence . The biotech's shares...
Previous 10 Next 10